Thorin L. Geister, n/a

Principal Scientific Expert Clinical Development
Merz Therapeutics GmbH, Germany

Poster(s):

• 400 Section - IncobotulinumtoxinA for the Treatment of Lower Limb Spasticity in Children and Adolescents with Cerebral Palsy: Evaluation of Lower Limb IncobotulinumtoxinA Efficacy (ELLIE)
  Tuesday, May 19, 2026

  6:00 PM - 7:30 PM PT

• 400 Section - Paving the way for a new local peripheral neuropathic pain treatment: Proof-of -concept clinical trial with AincobotulinmtoxinA (PaiNT)
  Tuesday, May 19, 2026

  6:00 PM - 7:30 PM PT